Chang‐Yuil Kang

Seoul National University — South Korea

Immunology and Microbiology · Life Sciences

41h-index4.9kcitations196works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(90), Immunotherapy and Immune Responses(67), T-cell and B-cell Immunology(44), Immune cells in cancer(32), Monoclonal and Polyclonal Antibodies Research(31)

Publications195 total

The Ad5/35 Platform-Based Vaccines for SARS-CoV-2: A Strategy to Counter Evolving Variants 2324
The Journal of Immunology·2025Open Access
Development and reproductive safety of AdCLD-CoV19, an adenoviral vector-based COVID-19 vaccine, in female Sprague–Dawley rats and their offspring
Toxicology and Applied Pharmacology·2025Open Access
Evaluation of Simultaneous Production Strategies for Adenoviral Vector-Based SARS-CoV-2 Multivalent Vaccines via an Expanded Allele-specific Competitive Blocker PCR Quantification Method
Analytical Chemistry·2025
Heterologous prime-boost vaccination drives stromal activation and adaptive immunity against SARS-CoV-2 variants
Frontiers in Immunology·2025· 4 citedOpen Access
Continuous Tracking for Effective Tackling: Ad5/35 Platform‐Based JN1 Lineage Vaccines Development in Response to Evolving SARS‐CoV‐2 Variants
Journal of Medical Virology·2025· 2 cited
Supplementary Figures from Activation of NKT Cells in an Anti-PD-1–Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells
2025Open Access
Data from Activation of NKT Cells in an Anti-PD-1–Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells
2025Open Access
Enhanced Stromal Activation at the Injection Site Boosts Immune Responses in Heterologous SARS-CoV-2 Vaccination
SSRN Electronic Journal·2025Open Access
Dose-dependent serological profiling of AdCLD-CoV19-1 vaccine in adults
mSphere·2024· 2 citedOpen Access
An open label, single arm phase II, multicenter trial of durvalumab and BVAC-C, in patients with HPV 16- or 18-positive cervical cancer and failure of first-line platinum-based chemotherapy (DURBAC).
Journal of Clinical Oncology·2024· 1 cited
Efficacy and safety of BVAC-C in HPV type 16- or 18–positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study
Frontiers in Immunology·2024· 5 citedOpen Access
Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform
Proceedings of the National Academy of Sciences·2024· 17 citedOpen Access
IL-17 and IL-21: Their Immunobiology and Therapeutic Potentials
Immune Network·2024· 32 citedOpen Access
Boosting with variant-matched adenovirus-based vaccines promotes neutralizing antibody responses against SARS-CoV-2 Omicron sublineages in mice
International Journal of Antimicrobial Agents·2023· 6 citedOpen Access
First-in-Human Phase 1 Study of a B Cell– and Monocyte-Based Immunotherapeutic Vaccine against HER2-Positive Advanced Gastric Cancer
Cancer Research and Treatment·2023· 12 citedOpen Access
Development of broadly protective COVID-19 vaccine against up-to-date variants based on adenovirus type 5/35 vector platform
The Journal of Immunology·2023Open Access
Supplementary Figures from GM-CSF Promotes Antitumor Immunity by Inducing Th9 Cell Responses
2023Open Access
Supplementary Figures from GM-CSF Promotes Antitumor Immunity by Inducing Th9 Cell Responses
2023Open Access
Data from GM-CSF Promotes Antitumor Immunity by Inducing Th9 Cell Responses
2023Open Access
Data from GM-CSF Promotes Antitumor Immunity by Inducing Th9 Cell Responses
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Hyun‐Jeong Ko(14), Yeonseok Chung(13), Yeon‐Jeong Kim(12), Sung‐Youl Ko(7), Kyoo‐A Lee(7), Sanghee Kim(6), Il‐Kyu Kim(6), Byung Seok Kim(6), Eun‐Ah Bae(6), Yoon Sook Lee(6), Dong‐Hyeon Kim(6), Woo‐Sung Chang(5), Hyungseok Seo(5), Insu Jeon(5), Boyeong Song(5), Heinz Köhler(5), Yun-Sun Kim(4), Jung-Mi Lee(4), Young‐Jun Park(4), Yun‐Sun Kim(4)